ROCKVILLE, Md., April 7, 2016 -- The Regulatory Affairs Professionals Society (RAPS) today released its new Regulatory Competency Framework, a tool to help design training and map professional and career development plans for regulatory professionals. The one-of-a-kind Framework is beneficial for individual professionals as well as regulatory employers and academics developing curriculum and education.
The Framework was previewed during last October's 2015 Regulatory Convergence conference. In his opening remarks, then-RAPS Chairman Rainer Voelksen told attendees: "Think about the nature of your work. It's not merely based on memorizing regulations. It is based on critical thinking, effectively integrating science, regulation, law, communication and business acumen. Your education and training needs to reflect this."
RAPS' Regulatory Competency Framework outlines a shared set of competencies for the profession, including knowledge and the necessary skills to apply it. Applicable across the globe, the Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels, and breaks down the basic competencies into clear, easy-to-understand statements, providing a foundation for individuals and organizations to customize their plans.
Several multinational organizations already have begun using the Framework. Former Chairman of RAPS' board of directors, Sue James, who is a vice president with GlaxoSmithKline (GSK), has used it to help define regulatory roles at GSK and called it "enormously valuable." "I leveraged the RAPS Regulatory Competency Framework to ensure alignment between GSK's competencies for regulatory staff and those identified by RAPS," said James. See the full interview with James at www.raps.org/Regulatory-Focus/RAPS-Latest/2016/04/07/24723/GSKs-Sue-James-Praises-RAPS-Regulatory-Competency-Framework.
To learn more about RAPS' Regulatory Competency Framework, or to request a copy, go to www.RAPS.org/rcf.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Shanghai and Singapore, and chapters and affiliates worldwide. www.RAPS.org
CONTACT: Zachary Brousseau
Senior Manager, Communications
RAPS
+1 301 770 2920, ext. 245
[email protected]


DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Italy Fines Apple €98.6 Million Over App Store Dominance
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 



